Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02996799
Other study ID # 409-16
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 2017
Est. completion date June 2023

Study information

Verified date September 2021
Source King Abdulaziz University
Contact Heidi Al-Wassia
Phone 966544800441
Email halwassia@kau.edu.sa
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

For preterm infants, deferred cord clamping has been shown to improve both short term and long-term neonatal outcomes without an established harm for both the mother and her infant.The interference with resuscitative measures for the neonate or the mother is a risk that continued to hamper the implementation of delayed cord clamping in many centers around the world.For that reason, the evidence now is seeking a time-honored, yet not adopted method of placental transfusion that involves milking of the umbilical cord.


Description:

Contrary to delayed cord clamping, milking of the umbilical cord is done at a faster rate and in shorter time.Recent evidence has demonstrated the efficacy and safety of umbilical cord milking for both term and preterm infants.A newer evidence comparing delayed cord clamping to umbilical cord milking in preterm infants demonstrated a higher initial hemoglobin, blood pressure and systemic blood flow in preterm infants allocated to the umbilical cord milking arm.However, concerns have been raised with regard to rapid infusion of large volume of blood in relatively shorter time predisposing to hyperperfusion injury including intraventricular hemorrhage. This is particularly problematic for preterm neonates as they are at higher risk of neurological injury. It has, though, advantage of shorter timeframe allowing for effective resuscitation of preterm neonates to start as soon as possible. Thus, with countering advantages and disadvantages, the practice has not been adopted at most places. The authors planned to conduct a randomized clinical trail to compare the efficacy and safety of umbilical cord milking to deferred cord clamping in preterm infants less than 32 weeks gestation.


Recruitment information / eligibility

Status Recruiting
Enrollment 180
Est. completion date June 2023
Est. primary completion date June 2023
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Preterm infants < 32 weeks gestation confirmed by first trimester US Exclusion Criteria: - Any proven or suspected congenital or chromosomal abnormalities - Placenta previa or abruption - Cord prolapse - Known Rh sensitization - Fetal hydrops - Monochorionic multiples

Study Design


Intervention

Other:
Umbilical cord milking
Milking of the umbilical cord at delivery

Locations

Country Name City State
Saudi Arabia King Abdulaziz University Hospital Jeddah

Sponsors (1)

Lead Sponsor Collaborator
King Abdulaziz University

Country where clinical trial is conducted

Saudi Arabia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Intraventricular haemorrhage Any IVH diagnosed by cranial ultrasound twenty eight days
Secondary Need for resuscitation Cardiac compression or medications at birth one hour
Secondary Apgar score at one minute Calculated Apgar score at one minute one minute after delivery
Secondary Apgar score at 5 minutes Calculated Apgar score at 5 minutes 5 minutes after delivery
Secondary The need for blood transfusion during hospital stay The number of blood transfusions during hospital stay one month
Secondary Venous Hgb Hgb at birth 2 days
Secondary Venous hematocrit Hematocrit at birth 2 days
Secondary Bilirubin level First bilirubin level after birth 24 hours after birth
Secondary Maximum bilirubin level Highest bilirubin level first week of life
Secondary Polycythemia If venous hematocrit more than 65% first 48 hours after birth
Secondary Respiratory distress syndrome The need for surfactant administration 48 hours after birth
Secondary Oxygen dependency first 28 days after birth and/or 36 weeks corrected age first 28 days after birth and 36 weeks corrected age
Secondary Need for volume administration Need for bolus administration first 24 hours after birth 24 hours after birth
Secondary Use of inotropes Use of any kind of inotropes in the first 24 hours First 24 hours
Secondary Necrotizing enterocolitis Bell stage II or more one month
Secondary Mortality in hospital Death before discharge one month
Secondary Sepsis Positive blood culture one month
Secondary Maternal mortality Maternal death after delivery in hospital 2 weeks
Secondary Post partum hemorrhage Maternal estimated blood loss more than 500 mls in the first 24 hours after birth one day
Secondary Maternal need for blood transfusion Maternal blood transfusion in the first 48 hours after delivery First 48 hours after delivery
Secondary Length of third stage The time from delivery of the infant until delivery of placenta 24 hours
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Completed NCT05502510 - Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
Not yet recruiting NCT03418012 - Prevention of sPTB With Early Cervical Pessary Treatment in Women at High Risk for PTB N/A
Not yet recruiting NCT03418311 - Cervical Pessary Treatment for Prevention of s PTB in Twin Pregnancies on Children`s Long-Term Outcome N/A
Completed NCT02993744 - Maternal Inflammatory Parameters Within Routine Treatment With Betamethasone N/A
Active, not recruiting NCT02673216 - Infection and Adverse Pregnancy Outcome
Completed NCT01683565 - Preemie Tots: A Pilot Study to Understand the Effects of Prematurity in Toddlerhood Phase 4
Completed NCT01412931 - Protein and Ultrasound Indicators of Preterm Birth N/A
Completed NCT01460576 - Improving Prematurity-Related Respiratory Outcomes at Vanderbilt N/A
Completed NCT02606058 - The Australian Placental Transfusion Study (APTS): Should Very Pre Term Babies Receive a Placental Blood Transfusion at Birth Via Deferring Cord Clamping Versus Standard Cord Clamping Procedures? N/A
Terminated NCT03715530 - Use of Placental Alpha Microglobulin-1(PAMG-1) to Diagnose Premature Rupture of Membranes in Pregnant Women N/A
Completed NCT00422526 - Progesterone for Prevention of Preterm Birth in Women With Short Cervix: Randomized Controlled Trial Phase 3
Enrolling by invitation NCT04251260 - Effectiveness of Positioning in Preterm Neonates N/A
Completed NCT03668860 - India Dexamethasone and Betamethasone Phase 1
Recruiting NCT03638037 - Correlation Between Maternal Vitamin D Level And Preterm Birth
Completed NCT02225353 - Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery Phase 2
Recruiting NCT03992534 - The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth Phase 1
Completed NCT03144141 - Association Between EHG and Risk of Preterm Delivery in Women Hospitalized for Threatened Premature Delivery N/A
Completed NCT05210985 - Examination of the Relationship Between Home Affordances With Development
Completed NCT04811742 - Effect of Immersion Bathing and Showering Applications on Comfort Level and Physiological Parameters of Newborn N/A